PharmaEssentia Corporation (TPE:6446)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
536.00
+6.00 (1.13%)
Apr 2, 2025, 1:30 PM CST

PharmaEssentia Statistics

Total Valuation

PharmaEssentia has a market cap or net worth of TWD 178.51 billion. The enterprise value is 158.42 billion.

Market Cap 178.51B
Enterprise Value 158.42B

Important Dates

The next estimated earnings date is Monday, May 12, 2025.

Earnings Date May 12, 2025
Ex-Dividend Date n/a

Share Statistics

PharmaEssentia has 333.04 million shares outstanding. The number of shares has increased by 3.59% in one year.

Current Share Class n/a
Shares Outstanding 333.04M
Shares Change (YoY) +3.59%
Shares Change (QoQ) +2.05%
Owned by Insiders (%) 8.79%
Owned by Institutions (%) 10.32%
Float 256.37M

Valuation Ratios

The trailing PE ratio is 60.36 and the forward PE ratio is 35.13.

PE Ratio 60.36
Forward PE 35.13
PS Ratio 18.23
PB Ratio 6.50
P/TBV Ratio 6.56
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 76.42, with an EV/FCF ratio of 94.03.

EV / Earnings 53.42
EV / Sales 16.27
EV / EBITDA 76.42
EV / EBIT 91.25
EV / FCF 94.03

Financial Position

The company has a current ratio of 9.94, with a Debt / Equity ratio of 0.04.

Current Ratio 9.94
Quick Ratio 9.34
Debt / Equity 0.04
Debt / EBITDA 0.47
Debt / FCF 0.57
Interest Coverage 78.23

Financial Efficiency

Return on equity (ROE) is 11.54% and return on invested capital (ROIC) is 4.05%.

Return on Equity (ROE) 11.54%
Return on Assets (ROA) 3.72%
Return on Invested Capital (ROIC) 4.05%
Return on Capital Employed (ROCE) 6.09%
Revenue Per Employee 74.31M
Profits Per Employee 22.64M
Employee Count 131
Asset Turnover 0.33
Inventory Turnover 0.86

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +62.67% in the last 52 weeks. The beta is 0.54, so PharmaEssentia's price volatility has been lower than the market average.

Beta (5Y) 0.54
52-Week Price Change +62.67%
50-Day Moving Average 639.42
200-Day Moving Average 625.41
Relative Strength Index (RSI) 33.65
Average Volume (20 Days) 1,797,827

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, PharmaEssentia had revenue of TWD 9.73 billion and earned 2.97 billion in profits. Earnings per share was 8.88.

Revenue 9.73B
Gross Profit 8.56B
Operating Income 1.74B
Pretax Income 2.99B
Net Income 2.97B
EBITDA 1.85B
EBIT 1.74B
Earnings Per Share (EPS) 8.88
Full Income Statement

Balance Sheet

The company has 21.05 billion in cash and 965.43 million in debt, giving a net cash position of 20.09 billion or 60.31 per share.

Cash & Cash Equivalents 21.05B
Total Debt 965.43M
Net Cash 20.09B
Net Cash Per Share 60.31
Equity (Book Value) 27.47B
Book Value Per Share 82.52
Working Capital 22.86B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 2.55 billion and capital expenditures -862.00 million, giving a free cash flow of 1.68 billion.

Operating Cash Flow 2.55B
Capital Expenditures -862.00M
Free Cash Flow 1.68B
FCF Per Share 5.06
Full Cash Flow Statement

Margins

Gross margin is 87.91%, with operating and profit margins of 17.83% and 30.46%.

Gross Margin 87.91%
Operating Margin 17.83%
Pretax Margin 30.76%
Profit Margin 30.46%
EBITDA Margin 18.97%
EBIT Margin 17.83%
FCF Margin 17.31%

Dividends & Yields

This stock pays an annual dividend of 1.10, which amounts to a dividend yield of 0.21%.

Dividend Per Share 1.10
Dividend Yield 0.21%
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -3.59%
Shareholder Yield -3.38%
Earnings Yield 1.66%
FCF Yield 0.94%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

PharmaEssentia has an Altman Z-Score of 29.21.

Altman Z-Score 29.21
Piotroski F-Score n/a